The FDA has approved semaglutide for the treatment of type 2 diabetes under the brand names Ozempic and Rybelsus
However, the use of such agents, often termed performance-enhancing drugs (PEDs), raises complex ethical, legal, and health-related considerations, necessitating a thorough understanding of their mechanisms of action, risks, and benefits
Another recent published work demonstrated that reduced NRF2 expression is responsible for the decline of neural stem/progenitor cell (NSPC) function, as it is found that NRF2 expression was suppressed in the aged NSPC, and overexpression of NRF2 in those old cells could render them to a similar state as the young NSPCs, by showing increasing cell survival and regeneration [126]
And this actually seems related to a broader societal trend of people searching for moreness